Axitinib (AG-013736) Mechanism of Action: VEGFR Inhibition in Tumor Endothelial Cells Research

Axitinib (AG-013736) MOA:Targeting VEGFR/PD-1 Pathway for Combination Immunotherapy

🎯 check Axitinib (AG-013736) product page

Axitinib (AG-013736) is a potent, broad-spectrum VEGFR, PDGFR, and cKIT tyrosine kinase inhibitor. It blocks VEGF/VEGFR and cKIT signaling by inhibiting receptor autophosphorylation, effectively suppressing tumor angiogenesis, cell proliferation, and migration.

Primary Applications and Mechanism of Action